魏炎;楚慧丽;关雅萍;王俊;毕经旺;

• 1:中国人民解放军济南军区总医院

摘要(Abstract)：

小分子非编码RNAs由siRNA,miRNA,piRNA和snoRNA组成。研究证实miRNAs在乳腺肿瘤的发生过程中具有重要调控作用,其它三种非编码RNAs的功能尚未研究清楚。本文旨在探讨miRNA通过调节细胞生长周期的方式参与乳腺癌的发生发展过程及其对乳腺癌干细胞的调控功能,并对乳腺肿瘤中有关piRNA和snoRNA的实验证据进行了总结。

关键词(KeyWords)： miRNA;非编码RNA;乳腺癌;致癌基因

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 魏炎;楚慧丽;关雅萍;王俊;毕经旺;

Email:

DOI:

参考文献(References)：

• [1]Ambros V.The functions of animal microRNAs.Nature.2004;431(7006):350-355.
• [2]Calin GA,Croce CM.MicroRNA signatures in human cancers.Nature Reviews.2006;6(11):857-866.
• [3]Esquela-Kerscher A,Slack FJ.Oncomirs-microRNAs with arolein cancer.Nature Reviews.2006;6(4):259-269.
• [4]Zhang B,Pan X,Cobb GP,et al.microRNAs as oncogenes andtumor suppressors.Dev Biol.2007;302(1):1-12.
• [5]Adams BD,Guttilla IK,White BA.Involvement of microRNAsinbreast cancer.Semin Reprod Med.2008;26(6):522-536.
• [6]Le Quesne J,Caldas C.Micro-RNAs and breast cancer.MolOn-col.2010;4(3):230-241.
• [7]Fu M,Wang C,Li Z,et al.Minireview:CyclinD1:normal andabnormal functions.Endocrinology.2004;145(12):5439-5447.
• [8]Deshpande A,Pastore A,Deshpande AJ,et al.3′UTR mediatedregulation of the cyclin D1proto-oncogene.Cell Cycle.2009;8(21):3584-3592.
• [9]Schetter AJ,Leung SY,Sohn JJ,et al.MicroRNA expression pro-files associated with prognosis and therapeutic outcome in colon adenocar-cinoma.JAMA.2008;299(4):425-436.
• [10]Yang N,Kaur S,Volinia S,etal.MicroRNA microarray identifiesLet-7i as a novel biomarkerand therapeutic target in human epithelialovarian cancer.CancerRes.2008;68(24):10307-10314.
• [11]Yu F,Yao H,Zhu P,et al.let-7 regulatesself renewal and tumor-igenicity of breast cancer cells.Cell.2007;131(6):1109-1123.
• [12]Schultz J,Lorenz P,Gross G,et al.MicroRNA let-7b targets im-portant cell cycle molecules in malignant melanomacells and interferes withanchorage-independent growth.Cell Res.2008;18(5):549-557.
• [13]Casimiro M,Crosariol M,Loro E,et al.ChIP-Sequencing of cy-clin D1 in mouse reveals a transcriptionalrole in chromosomal instability.JClin Invest.2012;6.
• [14]Kim YK,Yu J,Han TS,et al.Functional links between clusteredmicroRNAs:suppression ofcell-cycle inhibitors by microRNA clusters ingastric cancer.Nucleic Acids Res.2009;37(5):1672-1681.
• [15]Stinson S,Lackner MR,Adai AT,et al.miR-221/222 targetingof trichorhinophalangeal 1(TRPS1)promotesepithelial-to-mesenchymaltransition in breast cancer.SciSignal.2011;4(186):5.
• [16]Bourguignon LY,Spevak CC,Wong G,et al.Hyaluronan-CD44interaction with protein kinase C(epsilon)promotes oncogenicsignaling bythe stem cell marker Nanog and the Production ofmicroRNA-21,leadingto down-regulation of the tumor suppressorprotein PDCD4,anti-apopto-sis,and chemotherapy resistance inbreast tumor cells.J Biol Chem.2009;284(39):26533-26546.
• [17]Frankel LB,Christoffersen NR,Jacobsen A,et al.Programmedcell death 4(PDCD4)is an importantfunctional target of the microRNAmiR-21 in breast cancer cells.J Biol Chem.2008;283(2):1026-1033.
• [18]Wang P,Zou F,Zhang X,et al.microRNA-21 negatively regu-lates Cdc25A and cell cycle progressionin colon cancer cells.Cancer Res.2009;69(20):8157-8165.
• [19]Jin Y.3,3′-Diindolylmethane inhibits breast cancer cell growthviamiR-21-mediated Cdc25A degradation.Mol Cell Biochem.2011;358(1-2):345-354.
• [20]Mertens-Talcott SU,Chintharlapalli S,Li X,et al.The onco-genicmicroRNA-27a targets genes that regulate specificity proteintran-scription factors and the G2-M checkpoint in MDA-MB-231breast can-cer cells.Cancer Res.2007;67(22):11001-11011.
• [21]Gupta PB,Chaffer CL,Weinberg RA.Cancer stem cells:mirageorreality?Nat Med.2009;15(9):1010-1012.
• [22]Shimono Y,Zabala M,Cho RW,et al.Downregulation of miR-NA-200c links breast cancer stem cellswith normal stem cells.Cell.2009;138(3):592-603.
• [23]Gregory PA,Bert AG,Paterson EL,et al.The miR-200 familyand miR-205 regulate epithelial tomesenchymal transition by targetingZEB1 and SIP1.Nat CellBiol.2008;10(5):593-601.
• [24]Yu F,Jiao Y,Zhu Y,et al.MiR-34c downregulationvia DNAmethylation promotes self-renewal andepithelial-mesenchymal transitionin breast tumor-initiating cells.J Biol Chem.2012;287(1):465-473.
• [25]Zhu Y,Yu F,Jiao Y,et al.Reduced miR-128 in breast tu-mor-initiating cells induces chemotherapeutic resistancevia Bmi-1 andABCC5.Clin Cancer Res.2011;17(22):7105-7115.
• [26]Dong XY,Guo P,Boyd J,et al.Implicationof snoRNA U50 inhuman breast cancer.J Genet Genomics.2009;36(8):447-454.
• [27]Girard A,Sachidanandam R,Hannon GJ,et al.Agermline-specif-ic class of small RNAs binds mammalian Piwiproteins.Nature.2006;442(7099):199-202.
• [28]Lee EJ,Banerjee S,Zhou H,et al.Identification of piRNAs inthe central nervous system.RNA.2011;17(6):1090-1099.
• [29]Lee JH,Jung C,Javadian-Elyaderani P,et al.Pathways of prolif-eration and antiapoptosisdriven in breast cancer stem cells by stem cell pro-tein piwil2.Cancer Res.2010;70(11):4569-4579.
• [30]Farazi TA,Horlings HM,Ten Hoeve JJ,et al.MicroRNA se-quence and expression analysis inbreast tumors by deep sequencing.CancerRes.2011;71(13):4443-53.
• [31]Kim SJ,Oh JS,Shin JY,et al.Development of microRNA-145for therapeutic application inbreast cancer.J Control Release.2011;155(3):427-434.
• [32]Trang P,Medina PP,Wiggins JF,et al.Regression of murine lungtumors by the let-7 microRNA.Oncogene.2010;29(11):1580-1587.
• [33]Wiggins JF,Ruffino L,Kelnar K,et al.Development of a lungcancer therapeutic based on the tumorsuppressor microRNA-34.CancerRes.2010;70(14):5923-5930.
• [34]Kota J,Chivukula RR,O’Donnell KA,et al.Therapeutic mi-croRNA delivery suppressestumorigenesis in a murine liver cancer model.Cell.2009;137(6):1005-1017.
• [35]Rask L,Balslev E,Jorgensen S,etal.High expression of miR-21in tumor stroma correlates withincreased cancer cell proliferation in humanbreast cancer.APMIS.2011;119(10):663-673.
• [36]Asaga S,Kuo C,Nguyen T,Terpenning M,et al.Direct serumassay for microRNA-21 concentrations in early and advanced breast cancer.Clin Chem.2011;57(1):84-91.